Measuring and improving the timeliness of vancomycin therapeutic drug monitoring and potential patient safety impacts
Background: Timely vancomycin therapeutic drug monitoring (TDM) enables prompt dose adjustments and safe treatment. Local incidents prompted an investigation into the reasons for prolonged reporting times. Objectives: To investigate the variation in reporting times of vancomycin concentrations betwe...
Main Authors: | Belinda Chappell, Benita Suckling, Champika Pattullo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Exploratory Research in Clinical and Social Pharmacy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667276623001841 |
Similar Items
-
Therapeutic drug monitoring of vancomycin in an obese patient with renal insufficiency
by: Said Abuhasna, et al.
Published: (2011-01-01) -
Comparison of vancomycin serum levels prior to and post
therapeutic drug monitoring in patients admitted to hospital
by: Kaveh Eslami, et al.
Published: (2021-09-01) -
Clinical Response and Hospital Costs of Therapeutic Drug Monitoring for Vancomycin in Elderly Patients
by: Yun Kim, et al.
Published: (2022-01-01) -
Therapeutic drug monitoring of vancomycin in patients with infectious complications in traumatology and orthopedics
by: Borisov A.M., et al.
Published: (2020-03-01) -
Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
by: Kashif Hussain, et al.
Published: (2021-12-01)